vs
Side-by-side financial comparison of C.H. Robinson (CHRW) and Fresenius Medical Care AG (FMS). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $3.9B, roughly 1.4× C.H. Robinson). Fresenius Medical Care AG runs the higher net margin — 7.9% vs 3.5%, a 4.4% gap on every dollar of revenue. On growth, Fresenius Medical Care AG posted the faster year-over-year revenue change (-0.3% vs -6.5%).
C.H. Robinson Worldwide, Inc. is an American transportation company that includes third-party logistics (3PL). The company offers freight transportation, transportation management, brokerage and warehousing. It offers truckload, less than truckload, air freight, intermodal, and ocean transportation.
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
CHRW vs FMS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.9B | $5.5B |
| Net Profit | $136.3M | $434.2M |
| Gross Margin | — | 27.4% |
| Operating Margin | 4.6% | 11.7% |
| Net Margin | 3.5% | 7.9% |
| Revenue YoY | -6.5% | -0.3% |
| Net Profit YoY | -8.7% | 240.4% |
| EPS (diluted) | $1.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.9B | $5.5B | ||
| Q3 25 | $4.1B | — | ||
| Q2 25 | $4.1B | — | ||
| Q1 25 | $4.0B | — | ||
| Q4 24 | $4.2B | $5.5B | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.5B | — | ||
| Q1 24 | $4.4B | — |
| Q4 25 | $136.3M | $434.2M | ||
| Q3 25 | $163.0M | — | ||
| Q2 25 | $152.5M | — | ||
| Q1 25 | $135.3M | — | ||
| Q4 24 | $149.3M | $127.6M | ||
| Q3 24 | $97.2M | — | ||
| Q2 24 | $126.3M | — | ||
| Q1 24 | $92.9M | — |
| Q4 25 | — | 27.4% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 25.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 4.6% | 11.7% | ||
| Q3 25 | 5.3% | — | ||
| Q2 25 | 5.2% | — | ||
| Q1 25 | 4.4% | — | ||
| Q4 24 | 4.4% | 5.1% | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | 4.0% | — | ||
| Q1 24 | 2.9% | — |
| Q4 25 | 3.5% | 7.9% | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 3.7% | — | ||
| Q1 25 | 3.3% | — | ||
| Q4 24 | 3.6% | 2.3% | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 2.1% | — |
| Q4 25 | $1.12 | — | ||
| Q3 25 | $1.34 | — | ||
| Q2 25 | $1.26 | — | ||
| Q1 25 | $1.11 | — | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $0.80 | — | ||
| Q2 24 | $1.05 | — | ||
| Q1 24 | $0.78 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $160.9M | $1.7B |
| Total DebtLower is stronger | $1.1B | — |
| Stockholders' EquityBook value | $1.8B | $15.4B |
| Total Assets | $5.1B | $33.5B |
| Debt / EquityLower = less leverage | 0.59× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $160.9M | $1.7B | ||
| Q3 25 | $136.8M | — | ||
| Q2 25 | $156.0M | — | ||
| Q1 25 | $129.9M | — | ||
| Q4 24 | $145.8M | $1.3B | ||
| Q3 24 | $131.7M | — | ||
| Q2 24 | $113.2M | — | ||
| Q1 24 | $121.8M | — |
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.4B | — | ||
| Q1 25 | $1.4B | — | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — | ||
| Q1 24 | $1.7B | — |
| Q4 25 | $1.8B | $15.4B | ||
| Q3 25 | $1.9B | — | ||
| Q2 25 | $1.8B | — | ||
| Q1 25 | $1.7B | — | ||
| Q4 24 | $1.7B | $17.0B | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $5.1B | $33.5B | ||
| Q3 25 | $5.2B | — | ||
| Q2 25 | $5.3B | — | ||
| Q1 25 | $5.2B | — | ||
| Q4 24 | $5.3B | $36.3B | ||
| Q3 24 | $5.6B | — | ||
| Q2 24 | $5.5B | — | ||
| Q1 24 | $5.5B | — |
| Q4 25 | 0.59× | — | ||
| Q3 25 | 0.64× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.80× | — | ||
| Q3 24 | 0.95× | — | ||
| Q2 24 | 1.07× | — | ||
| Q1 24 | 1.19× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $305.4M | $2.9B |
| Free Cash FlowOCF − Capex | $302.4M | — |
| FCF MarginFCF / Revenue | 7.7% | — |
| Capex IntensityCapex / Revenue | 0.1% | — |
| Cash ConversionOCF / Net Profit | 2.24× | 6.67× |
| TTM Free Cash FlowTrailing 4 quarters | $894.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $305.4M | $2.9B | ||
| Q3 25 | $275.4M | — | ||
| Q2 25 | $227.1M | — | ||
| Q1 25 | $106.5M | — | ||
| Q4 24 | $267.9M | $2.6B | ||
| Q3 24 | $108.1M | — | ||
| Q2 24 | $166.4M | — | ||
| Q1 24 | $-33.3M | — |
| Q4 25 | $302.4M | — | ||
| Q3 25 | $269.5M | — | ||
| Q2 25 | $219.8M | — | ||
| Q1 25 | $103.2M | — | ||
| Q4 24 | $265.3M | — | ||
| Q3 24 | $103.3M | — | ||
| Q2 24 | $159.8M | — | ||
| Q1 24 | $-41.9M | — |
| Q4 25 | 7.7% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 5.3% | — | ||
| Q1 25 | 2.5% | — | ||
| Q4 24 | 6.3% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | 3.6% | — | ||
| Q1 24 | -1.0% | — |
| Q4 25 | 0.1% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.2% | — | ||
| Q1 25 | 0.1% | — | ||
| Q4 24 | 0.1% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.2% | — |
| Q4 25 | 2.24× | 6.67× | ||
| Q3 25 | 1.69× | — | ||
| Q2 25 | 1.49× | — | ||
| Q1 25 | 0.79× | — | ||
| Q4 24 | 1.79× | 20.20× | ||
| Q3 24 | 1.11× | — | ||
| Q2 24 | 1.32× | — | ||
| Q1 24 | -0.36× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CHRW
| North American Service Transportation NAST | $2.8B | 72% |
| Global Forwarding | $731.0M | 19% |
| Sourcing | $340.9M | 9% |
FMS
Segment breakdown not available.
